Adult Acute Myeloblastic Leukemia Without Maturation (M1) Terminated Phase 2 Trials for 2'-Deoxycytidine (DB02594)

IndicationStatusPhase
DBCOND0028523 (Adult Acute Myeloblastic Leukemia Without Maturation (M1))Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01607645Decitabine Followed by Idarubicin and Cytarabine in Treating Patients With Relapsed or Refractory AML and MDSTreatment
NCT02029417Omacetaxine Mepesuccinate, Cytarabine, and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid LeukemiaTreatment